EGFR c.2239_2241del ;(p.L747del)

Variant ID: 7-55242467-AATT-A

NM_005228.3(EGFR):c.2239_2241del;(p.L747del)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Preclinical assessment of combination therapy of EGFR tyrosine kinase inhibitors in a highly heterogeneous tumor model.

Oncogene
Ikeuchi, Hiroshi H; Hirose, Takeshi T; Ikegami, Masachika M; Takamochi, Kazuya K; Suzuki, Kenji K; Mano, Hiroyuki H; Kohsaka, Shinji S
Publication Date: 2022-04

Variant appearance in text: EGFR: L747del
PubMed Link: 35304574
Variant Present in the following documents:
  • 41388_2022_Article_2263.pdf
View BVdb publication page



Assessment of EGFR mutation status in lung adenocarcinoma by immunohistochemistry using antibodies specific to the two major forms of mutant EGFR.

The Journal Of Molecular Diagnostics : Jmd
Brevet, Marie M; Arcila, Maria M; Ladanyi, Marc M
Publication Date: 2010-03

Variant appearance in text: EGFR: L747del
PubMed Link: 20093391
Variant Present in the following documents:
  • Main text
View BVdb publication page